Mechanistically, during the onset of arthritis, IL-23 promotes IL-21 and IL-22 production by Th17 cells, which suppresses St6gal1 expression in plasma cells, resulting in increased levels of the pathogenic form of IgG glycosylation. This evidence concerns the gene IL23A and Arthritis.